2-Chloro-5-methyl-7H-pyrrolo[2,3-d]pyrimidine, 95.0%, 250mg

N-(2-Hydroxyethyl)acrylamide (stabilized with MEHQ)>98.0%(GC)(T)25g

N-benzyl-1-(1-benzylpiperidin-4-yl)methanamine, 98%, 5g

4,5-DIFLUOROPYRIDIN-2-AMINE, 95.0%, 250mg

C8-Alkyne-dU-CEP, ≥95%, 250 mg, plastic packaging.

6-Methoxy-1H-indazole-3-carboxylic acid, 95.0%, 5g

(S)-1-(4-Fluorophenyl)-5-(2-oxo-4-phenyloxazolidin-3-yl)pentane-1,5-dione, 95.0%, 1g

tert-Butyl 8-hydroxy-5-azaspiro[3.5]nonane-5-carboxylate, 95.0%, 100mg

BENZYL (3-METHYLAZETIDIN-3-YL)CARBAMATE HCL, 95.0%, 100mg

tert-Butyl 1-(2-methoxyacetyl)piperidin-4-ylcarbamate, 95.0%, 1g

4-(4H-1,2,4-Triazol-4-yl)phenol, 95.0%, 10g

(S)-tert-Butyl 2-formylpiperidine-1-carboxylate, 95.0%, 1g

Canertinib, 98%, 10mg